These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18355693)

  • 1. 99mTc-NC100692--a tracer for imaging vitronectin receptors associated with angiogenesis: a preclinical investigation.
    Edwards D; Jones P; Haramis H; Battle M; Lear R; Barnett DJ; Edwards C; Crawford H; Black A; Godden V
    Nucl Med Biol; 2008 Apr; 35(3):365-75. PubMed ID: 18355693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.
    Dearling JL; Barnes JW; Panigrahy D; Zimmerman RE; Fahey F; Treves ST; Morrison MS; Kieran MW; Packard AB
    Nucl Med Biol; 2013 Aug; 40(6):788-94. PubMed ID: 23701702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.
    Bach-Gansmo T; Danielsson R; Saracco A; Wilczek B; Bogsrud TV; Fangberget A; Tangerud A; Tobin D
    J Nucl Med; 2006 Sep; 47(9):1434-9. PubMed ID: 16954550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc demotate 1: biodistribution and elimination characteristics in rats.
    Kopecky M; Trejtnar F; Laznicek M; Laznickova A; Semecky V; Maina T; Nock B
    Nucl Med Commun; 2005 Jun; 26(6):549-54. PubMed ID: 15891599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.
    Sancey L; Ardisson V; Riou LM; Ahmadi M; Marti-Batlle D; Boturyn D; Dumy P; Fagret D; Ghezzi C; Vuillez JP
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2037-47. PubMed ID: 17674000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results.
    Maina T; Nock B; Nikolopoulou A; Sotiriou P; Loudos G; Maintas D; Cordopatis P; Chiotellis E
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):742-53. PubMed ID: 12029547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human urinary excretion of NC100692, an RGD-peptide for imaging angiogenesis.
    Roed L; Oulie I; McParland BJ; Skotland T
    Eur J Pharm Sci; 2009 Jun; 37(3-4):279-83. PubMed ID: 19491016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide.
    Lister-James J; Knight LC; Maurer AH; Bush LR; Moyer BR; Dean RT
    J Nucl Med; 1996 May; 37(5):775-81. PubMed ID: 8965144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and renal handling of 99mTc-labeled peptides.
    Trejtnar F; Laznicek M; Laznickova A; Mather SJ
    J Nucl Med; 2000 Jan; 41(1):177-82. PubMed ID: 10647621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biodistribution of NC100668 and the effect of excess NC100668 on the biodistribution and kidney retention of (99m)Tc-NC100668 in the rat.
    Edwards D; Lewis J; Battle M; Lear R; Farrar G; Barnett DJ; Godden V; Edwards C; Oliveira A; Ahlström H
    Nucl Med Biol; 2007 Apr; 34(3):315-23. PubMed ID: 17383581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (99m)Tc-NC100668, a new tracer for imaging venous thromboemboli: pre-clinical biodistribution and incorporation into plasma clots in vivo and in vitro.
    Edwards D; Lewis J; Battle M; Lear R; Farrar G; Barnett DJ; Godden V; Oliveira A; Coombes C; Ahlström H
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1258-65. PubMed ID: 16804686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of NC100692, a new tracer for 99mTc-imaging of angiogenesis, in human plasma using reversed-phase liquid chromatography coupled with electrospray ionization ion-trap mass spectrometry.
    Oulie I; Roed L; Toft KG; Skotland T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):605-10. PubMed ID: 17353156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo and in vitro metabolic profile of 99mTc-NC100668, a new tracer for imaging venous thromboembolism: identification and biodistribution of the principal radiolabeled metabolite.
    Edwards D; Battle M; Lear R; Farrar G; Barnett DJ; Godden V; Coombes C; Oliveira A; Ahlström H
    Drug Metab Dispos; 2006 Jul; 34(7):1128-35. PubMed ID: 16611856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692.
    Axelsson R; Bach-Gansmo T; Castell-Conesa J; McParland BJ;
    Acta Radiol; 2010 Feb; 51(1):40-6. PubMed ID: 20001475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.
    Maina T; Nock BA; Cordopatis P; Bernard BF; Breeman WA; van Gameren A; van den Berg R; Reubi JC; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):831-40. PubMed ID: 16568203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8.
    Krause S; Rennen HJ; Boerman OC; Baumann S; Cyr JE; Manchanda R; Lister-James J; Corstens FC; Dinkelborg LM
    Nucl Med Biol; 2007 Nov; 34(8):925-32. PubMed ID: 17998094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
    Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
    Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
    Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
    Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and preclinical evaluation of technetium-99m-labeled hippurate analogues.
    Fukuoka M; Kiyohara T; Kobayashi T; Kojima S; Tanaka A; Kubodera A
    Nucl Med Biol; 1995 Feb; 22(2):181-91. PubMed ID: 7767311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of bidentate chelators on lipophilicity, stability, and biodistribution characteristics of cationic 99mTc-nitrido complexes.
    Kim YS; He Z; Hsieh WY; Liu S
    Bioconjug Chem; 2007; 18(3):929-36. PubMed ID: 17352455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.